Symbols / AHCO Stock $9.89 +1.64% AdaptHealth Corp.

Healthcare • Medical Devices • United States • NCM
AHCO (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Ms. Suzanne M. Foster M.P.H.
Exch · Country NCM · United States
Market Cap 1.35B
Enterprise Value 3.28B
Income -79.63M
Sales 3.29B
FCF (ttm) 267.90M
Book/sh 11.32
Cash/sh 0.36
Employees 10,900
Insider 10d —
IPO May 31, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 8.41
PEG —
P/S 0.41
P/B 0.87
P/C —
EV/EBITDA 5.62
EV/Sales 1.00
Quick Ratio 0.61
Current Ratio 0.93
Debt/Eq 132.10
LT Debt/Eq —
EPS (ttm) -0.59
EPS next Y 1.18
EPS Growth —
Revenue Growth 5.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-04
Earnings (prior) 2026-05-05
ROA 2.64%
ROE -4.85%
ROIC —
Gross Margin 20.40%
Oper. Margin 0.67%
Profit Margin -2.42%
Shs Outstand 136.05M
Shs Float 85.69M
Insider Own 8.06%
Instit Own 106.67%
Short Float 6.98%
Short Ratio 4.55
Short Interest 7.18M
52W High 13.43
vs 52W High -26.36%
52W Low 8.06
vs 52W Low 22.70%
Beta 1.46
Impl. Vol. 58.20%
Rel Volume 0.61
Avg Volume 1.50M
Volume 920.38K
Target (mean) $14.00
Tgt Median $14.00
Tgt Low $11.00
Tgt High $18.00
# Analysts 8
Recom Buy
Prev Close $9.73
Price $9.89
Change 1.64%
About

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$14.00
Mean price target
2. Current target
$9.89
Latest analyst target
3. DCF / Fair value
$35.44
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.89
Low
$11.00
High
$18.00
Mean
$14.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-11 main RBC Capital Outperform → Outperform $15
2026-05-06 main Canaccord Genuity Buy → Buy $16
2026-05-06 main UBS Buy → Buy $14
2026-04-13 main Truist Securities Buy → Buy $14
2026-02-26 main Leerink Partners Outperform → Outperform $12
2025-11-06 main Canaccord Genuity Buy → Buy $15
2025-05-12 main Truist Securities Buy → Buy $13
2025-05-08 main RBC Capital Outperform → Outperform $13
2025-02-27 main Baird Outperform → Outperform $16
2025-02-26 main Canaccord Genuity Buy → Buy $14
2025-02-26 main RBC Capital Outperform → Outperform $14
2025-02-26 main Truist Securities Buy → Buy $14
2025-02-13 main UBS Buy → Buy $11
2024-11-19 main RBC Capital Outperform → Outperform $11
2024-11-15 main Truist Securities Buy → Buy $12
2024-11-06 main UBS Buy → Buy $12
2024-11-06 main Canaccord Genuity Buy → Buy $13
2024-11-06 main Baird Outperform → Outperform $14
2024-08-12 reit RBC Capital Outperform → Outperform $13
2024-05-15 main Truist Securities Buy → Buy $13
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-01 SCHUSTER RUSSELL E. III Officer — 11,275 $10.06 $113,426
2026-05-27 MCFADDEN DANIEL EDWARD Chief Operating Officer — 20,134 $0.00 $0
2026-03-20 CASHIN RICHARD M JR Beneficial Owner of more than 10% of a Class of Security — 447,827 $9.91 $4,438,928
2026-03-20 OEP VII GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 447,827 $9.91 $4,438,928
2026-03-13 PRAST ALBERT A. Chief Technology Officer — 89,451 $4.38 $391,795
2026-03-13 PRAST ALBERT A. Chief Technology Officer — 89,451 $4.38 $391,795
2026-03-12 CASHIN RICHARD M JR Beneficial Owner of more than 10% of a Class of Security — 2,046,691 $9.73 $19,912,148
2026-03-12 OEP VII GP, L.L.C. Beneficial Owner of more than 10% of a Class of Security — 2,046,691 $9.73 $19,912,148
2026-03-05 WEAVER SUSAN T. Director — 73,472 $0.00 $0
2026-02-27 WOLF DALE B Director — 8,000 $8.96 $71,680
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,244.86
-0.49%
3,260.97
+1.90%
3,200.18
+7.73%
2,970.59
Operating Revenue
3,244.86
-0.49%
3,260.97
+1.90%
3,200.18
+7.73%
2,970.59
Cost Of Revenue
2,635.66
+2.16%
2,579.88
+0.15%
2,576.11
+7.77%
2,390.48
Reconciled Cost Of Revenue
2,294.37
+1.54%
2,259.59
+0.41%
2,250.41
+6.95%
2,104.19
Gross Profit
609.20
-10.56%
681.09
+9.14%
624.07
+7.58%
580.12
Operating Expense
422.93
+4.61%
404.28
+3.22%
391.68
+0.51%
389.70
Selling General And Administration
382.29
+6.42%
359.24
+7.37%
334.59
+3.01%
324.81
General And Administrative Expense
382.29
+6.42%
359.24
+7.37%
334.59
+3.01%
324.81
Other Gand A
382.29
+6.42%
359.24
+7.37%
334.59
+3.01%
324.81
Other Operating Expenses
—
—
—
—
Total Expenses
3,058.59
+2.49%
2,984.16
+0.55%
2,967.79
+6.75%
2,780.18
Operating Income
186.27
-32.71%
276.81
+19.12%
232.39
+22.04%
190.41
Total Operating Income As Reported
90.87
-65.54%
263.73
+144.07%
-598.40
-414.27%
190.41
EBITDA
472.53
-24.76%
628.02
+398.06%
-210.70
-137.73%
558.49
Normalized EBITDA
567.92
-11.17%
639.35
+9.18%
585.60
+8.18%
541.34
Reconciled Depreciation
381.93
+4.54%
365.33
-4.56%
382.78
+9.00%
351.18
EBIT
90.60
-65.51%
262.69
+144.26%
-593.49
-386.27%
207.32
Total Unusual Items
-95.39
-741.95%
-11.33
+98.58%
-796.30
-4741.01%
17.16
Total Unusual Items Excluding Goodwill
-95.39
-741.95%
-11.33
+98.58%
-796.30
-4741.01%
17.16
Special Income Charges
-95.39
-521.41%
-15.35
+98.15%
-830.79
0.00
Other Special Charges
—
2.27
—
—
Impairment Of Capital Assets
128.00
+878.70%
13.08
-98.43%
830.79
0.00
Restructuring And Mergern Acquisition
—
—
0.00
0.00
Net Income
-70.79
-178.29%
90.42
+113.32%
-678.89
-1079.42%
69.32
Pretax Income
-15.15
-111.14%
136.02
+118.79%
-723.78
-839.29%
97.90
Net Non Operating Interest Income Expense
-105.75
+16.51%
-126.67
+2.79%
-130.30
-19.09%
-109.41
Interest Expense Non Operating
105.75
-16.51%
126.67
-2.79%
130.30
+19.09%
109.41
Net Interest Income
-105.75
+16.51%
-126.67
+2.79%
-130.30
-19.09%
-109.41
Interest Expense
105.75
-16.51%
126.67
-2.79%
130.30
+19.09%
109.41
Other Income Expense
-95.67
-577.38%
-14.12
+98.29%
-825.87
-4985.37%
16.91
Other Non Operating Income Expenses
-0.27
+90.19%
-2.79
+90.55%
-29.57
-11586.17%
-0.25
Gain On Sale Of Security
—
4.02
-88.34%
34.48
+100.97%
17.16
Gain On Sale Of Business
32.60
0.00
0.00
—
Tax Provision
50.88
+23.39%
41.24
+184.15%
-49.00
-297.84%
24.77
Tax Rate For Calcs
0.00
-30.69%
0.00
+345.59%
0.00
-73.12%
0.00
Tax Effect Of Unusual Items
-20.03
-483.53%
-3.43
+93.66%
-54.15
-1347.39%
4.34
Net Income Including Noncontrolling Interests
-66.04
-169.68%
94.78
+114.05%
-674.78
-1022.68%
73.13
Net Income From Continuing Operation Net Minority Interest
-70.79
-178.29%
90.42
+113.32%
-678.89
-1079.42%
69.32
Net Income From Continuing And Discontinued Operation
-70.79
-178.29%
90.42
+113.32%
-678.89
-1079.42%
69.32
Net Income Continuous Operations
-66.04
-169.68%
94.78
+114.05%
-674.78
-1022.68%
73.13
Minority Interests
-4.76
-9.13%
-4.36
-5.91%
-4.12
-7.81%
-3.82
Normalized Income
4.57
-95.36%
98.32
+55.42%
63.26
+11.97%
56.50
Net Income Common Stockholders
-70.79
-185.55%
82.75
+112.19%
-678.89
-1169.99%
63.45
Otherunder Preferred Stock Dividend
—
—
0.00
-100.00%
5.87
Diluted EPS
-0.52
-185.25%
0.61
+111.49%
-5.31
-1709.09%
0.33
Basic EPS
-0.52
-183.87%
0.62
+112.25%
-5.06
-1176.60%
0.47
Basic Average Shares
135.15
+1.04%
133.76
-0.30%
134.16
-0.01%
134.18
Diluted Average Shares
135.15
-0.28%
135.53
+0.83%
134.42
-3.29%
138.99
Diluted NI Availto Com Stockholders
-70.79
-185.55%
82.75
+111.60%
-713.38
-1641.07%
46.29
Average Dilution Earnings
0.00
0.00
+100.00%
-34.48
-100.97%
-17.16
Depreciation Amortization Depletion Income Statement
40.64
-9.78%
45.05
-21.09%
57.09
-12.02%
64.89
Depreciation And Amortization In Income Statement
40.64
-9.78%
45.05
-21.09%
57.09
-12.02%
64.89
Preferred Stock Dividends
—
7.67
—
5.87
Rent Expense Supplemental
74.39
+3.50%
71.87
+5.12%
68.38
+3.63%
65.98
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4,316.58
-3.80%
4,486.95
-0.48%
4,508.65
-13.62%
5,219.59
Current Assets
728.90
-3.56%
755.79
+16.45%
649.02
+10.89%
585.31
Cash Cash Equivalents And Short Term Investments
106.14
-3.29%
109.75
+42.28%
77.13
+66.69%
46.27
Cash And Cash Equivalents
106.14
-3.29%
109.75
+42.28%
77.13
+66.69%
46.27
Cash Equivalents
—
—
—
0.00
Cash Financial
106.14
-3.29%
109.75
—
46.27
Receivables
370.90
-9.10%
408.02
+4.91%
388.91
+8.29%
359.15
Accounts Receivable
370.90
-9.10%
408.02
+4.91%
388.91
+8.29%
359.15
Inventory
151.25
+8.16%
139.84
+23.05%
113.64
-11.05%
127.75
Prepaid Assets
—
—
—
—
Assets Held For Sale Current
0.00
-100.00%
52.75
0.00
—
Other Current Assets
100.62
+121.47%
45.43
-34.48%
69.34
+32.99%
52.14
Total Non Current Assets
3,587.68
-3.85%
3,731.16
-3.33%
3,859.63
-16.72%
4,634.28
Net PPE
674.22
+9.03%
618.36
-3.01%
637.53
+2.50%
622.01
Gross PPE
1,198.37
+5.44%
1,136.53
+5.77%
1,074.51
+6.90%
1,005.20
Accumulated Depreciation
-524.15
-1.15%
-518.18
-18.58%
-436.98
-14.04%
-383.19
Machinery Furniture Equipment
86.67
-31.37%
126.30
+4.79%
120.53
+13.47%
106.22
Other Properties
1,111.70
+10.04%
1,010.23
+5.90%
953.98
+6.12%
898.97
Goodwill And Other Intangible Assets
2,626.55
-5.54%
2,780.71
-2.61%
2,855.12
-23.00%
3,708.07
Goodwill
2,541.43
-5.00%
2,675.17
-1.83%
2,724.96
-23.14%
3,545.30
Other Intangible Assets
85.12
-19.35%
105.55
-18.91%
130.16
-20.04%
162.77
Non Current Deferred Assets
267.79
-14.85%
314.50
-9.06%
345.85
+22.74%
281.79
Non Current Deferred Taxes Assets
267.79
-14.85%
314.50
-9.06%
345.85
+22.74%
281.79
Other Non Current Assets
19.12
+8.73%
17.58
-16.77%
21.13
-5.74%
22.41
Total Liabilities Net Minority Interest
2,790.25
-4.08%
2,908.83
-4.38%
3,041.98
-0.65%
3,061.83
Current Liabilities
712.39
+25.65%
566.99
+5.58%
537.00
+17.71%
456.21
Payables And Accrued Expenses
503.90
+15.78%
435.24
+11.03%
391.99
+16.15%
337.50
Payables
352.38
+25.02%
281.85
+4.84%
268.84
+20.83%
222.50
Accounts Payable
352.38
+25.02%
281.85
+33.26%
211.50
-4.94%
222.50
Other Payable
—
—
57.34
+29.60%
44.24
Current Accrued Expenses
151.52
-1.22%
153.38
+24.55%
123.15
+7.09%
114.99
Current Debt And Capital Lease Obligation
68.74
+13.61%
60.51
-34.06%
91.76
+36.52%
67.21
Current Debt
20.31
+25.00%
16.25
-69.55%
53.37
+52.48%
35.00
Other Current Borrowings
20.31
+25.00%
16.25
-69.55%
53.37
+52.48%
35.00
Current Capital Lease Obligation
48.43
+9.42%
44.26
+15.28%
38.39
+19.19%
32.21
Current Deferred Liabilities
59.84
+71.25%
34.94
-9.40%
38.57
+21.90%
31.64
Current Deferred Revenue
59.84
+71.25%
34.94
-9.40%
38.57
+21.90%
31.64
Other Current Liabilities
30.11
-10.26%
33.55
+128.61%
14.68
-26.12%
19.86
Total Non Current Liabilities Net Minority Interest
2,077.86
-11.27%
2,341.84
-6.51%
2,504.98
-3.86%
2,605.61
Long Term Debt And Capital Lease Obligation
1,834.06
-11.39%
2,069.83
-6.04%
2,202.89
-2.60%
2,261.61
Long Term Debt
1,715.98
-12.67%
1,964.92
-6.19%
2,094.61
-2.72%
2,153.27
Long Term Capital Lease Obligation
118.07
+12.55%
104.91
-3.11%
108.28
-0.06%
108.34
Other Non Current Liabilities
243.80
-10.37%
272.02
-9.96%
302.09
-1.12%
305.50
Stockholders Equity
1,518.56
-3.35%
1,571.14
+7.73%
1,458.45
-32.20%
2,151.16
Common Stock Equity
1,518.56
-3.35%
1,571.14
+7.73%
1,458.45
-32.20%
2,151.16
Capital Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Preferred Stock
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Share Issued
135.45
-1.52%
137.54
+0.71%
136.57
+1.02%
135.19
Ordinary Shares Number
132.52
-1.55%
134.60
+1.48%
132.63
-1.34%
134.44
Treasury Shares Number
2.94
+0.00%
2.94
-25.41%
3.94
+424.09%
0.75
Additional Paid In Capital
2,176.99
+0.95%
2,156.60
+0.31%
2,149.95
+0.93%
2,130.15
Retained Earnings
-632.97
-12.59%
-562.18
+13.86%
-652.60
-2581.84%
26.30
Gains Losses Not Affecting Retained Earnings
0.08
-96.54%
2.25
-48.28%
4.36
-49.89%
8.69
Treasury Stock
25.55
+0.00%
25.55
-40.95%
43.27
+209.23%
13.99
Minority Interest
7.76
+11.32%
6.97
-15.12%
8.21
+24.47%
6.60
Other Equity Adjustments
0.08
-96.54%
2.25
-48.28%
4.36
-49.89%
8.69
Total Equity Gross Minority Interest
1,526.32
-3.28%
1,578.12
+7.60%
1,466.67
-32.03%
2,157.76
Total Capitalization
3,234.55
-8.53%
3,536.07
-0.48%
3,553.07
-17.46%
4,304.43
Working Capital
16.51
-91.26%
188.80
+68.54%
112.02
-13.22%
129.09
Invested Capital
3,254.86
-8.37%
3,552.32
-1.50%
3,606.43
-16.89%
4,339.42
Total Debt
1,902.80
-10.68%
2,130.34
-7.16%
2,294.65
-1.47%
2,328.82
Net Debt
1,630.16
-12.89%
1,871.42
-9.63%
2,070.85
-3.32%
2,141.99
Capital Lease Obligations
166.50
+11.62%
149.16
+1.70%
146.67
+4.35%
140.56
Net Tangible Assets
-1,107.99
+8.40%
-1,209.57
+13.40%
-1,396.66
+10.29%
-1,556.91
Tangible Book Value
-1,107.99
+8.40%
-1,209.57
+13.40%
-1,396.66
+10.29%
-1,556.91
Current Provisions
49.80
+1710.91%
2.75
—
—
Derivative Product Liabilities
—
—
0.00
-100.00%
38.50
Interest Payable
28.45
-1.29%
28.82
-1.74%
29.33
+1.56%
28.88
Preferred Stock Equity
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
601.77
+11.06%
541.84
+12.73%
480.67
+28.57%
373.87
Cash Flow From Continuing Operating Activities
601.77
+11.06%
541.84
+12.73%
480.67
+28.57%
373.87
Net Income From Continuing Operations
-66.04
-169.68%
94.78
+114.05%
-674.78
-1022.68%
73.13
Depreciation Amortization Depletion
381.93
+4.54%
365.33
-4.56%
382.78
+9.00%
351.18
Depreciation And Amortization
381.93
+4.54%
365.33
-4.56%
382.78
+9.00%
351.18
Other Non Cash Items
54.87
+9.98%
49.89
+14.97%
43.40
+16.61%
37.21
Stock Based Compensation
21.88
+47.02%
14.88
-33.77%
22.47
+0.32%
22.40
Asset Impairment Charge
128.00
+878.70%
13.08
-98.43%
830.79
0.00
Deferred Tax
47.16
+47.16%
32.05
+151.20%
-62.59
-447.06%
18.04
Deferred Income Tax
47.16
+47.16%
32.05
+151.20%
-62.59
-447.06%
18.04
Operating Gains Losses
-32.60
-1441.47%
-2.12
+94.17%
-36.28
-80.57%
-20.09
Gain Loss On Investment Securities
—
-4.39
+87.91%
-36.28
-80.57%
-20.09
Change In Working Capital
66.58
+355.49%
-26.06
-3.78%
-25.11
+76.75%
-108.00
Change In Receivables
30.99
+218.19%
-26.22
+9.16%
-28.86
-13709.57%
-0.21
Changes In Account Receivables
30.99
+218.19%
-26.22
+9.16%
-28.86
-13709.57%
-0.21
Change In Inventory
-11.49
+59.06%
-28.07
-280.70%
15.53
+346.52%
-6.30
Change In Prepaid Assets
-61.07
-323.50%
27.32
+234.57%
-20.30
-54.49%
-13.14
Change In Other Working Capital
—
—
—
-31.21
Change In Other Current Liabilities
108.16
+11943.99%
0.90
-89.47%
8.53
+109.65%
-88.34
Investing Cash Flow
-303.19
+2.28%
-310.27
+13.16%
-357.28
+13.11%
-411.17
Cash Flow From Continuing Investing Activities
-303.19
+2.28%
-310.27
+13.16%
-357.28
+13.11%
-411.17
Net PPE Purchase And Sale
-382.39
-24.94%
-306.06
+9.31%
-337.46
+13.79%
-391.42
Purchase Of PPE
-382.39
-24.94%
-306.06
+9.31%
-337.46
+13.79%
-391.42
Capital Expenditure
-382.39
-24.94%
-306.06
+9.31%
-337.46
+13.79%
-391.42
Net Investment Purchase And Sale
0.00
0.00
+100.00%
-0.13
+82.49%
-0.73
Purchase Of Investment
0.00
0.00
+100.00%
-0.13
+82.49%
-0.73
Sale Of Investment
—
—
—
0.00
Net Business Purchase And Sale
78.04
+918.39%
-9.54
+51.56%
-19.69
-3.52%
-19.02
Purchase Of Business
-42.38
-344.40%
-9.54
+51.56%
-19.69
-3.52%
-19.02
Gain Loss On Sale Of Business
-32.60
0.00
0.00
—
Net Other Investing Changes
1.16
-78.25%
5.32
—
—
Financing Cash Flow
-302.19
-51.89%
-198.95
-115.01%
-92.53
-40.09%
-66.05
Cash Flow From Continuing Financing Activities
-302.19
-51.89%
-198.95
-115.01%
-92.53
-40.09%
-66.05
Net Issuance Payments Of Debt
-268.48
-49.27%
-179.87
-247.44%
-51.77
-43.10%
-36.18
Issuance Of Debt
0.00
-100.00%
253.48
+406.95%
50.00
0.00
Repayment Of Debt
-268.48
+38.04%
-433.34
-325.81%
-101.77
-181.32%
-36.18
Long Term Debt Issuance
0.00
-100.00%
253.48
+406.95%
50.00
0.00
Long Term Debt Payments
-268.48
+38.04%
-433.34
-325.81%
-101.77
-181.32%
-36.18
Net Long Term Debt Issuance
-268.48
-49.27%
-179.87
-247.44%
-51.77
-43.10%
-36.18
Net Common Stock Issuance
0.00
0.00
+100.00%
-29.27
-109.23%
-13.99
Common Stock Payments
0.00
0.00
+100.00%
-29.27
-109.23%
-13.99
Cash Dividends Paid
—
—
—
—
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-29.27
-109.23%
-13.99
Proceeds From Stock Option Exercised
1.21
-30.44%
1.74
-33.50%
2.62
-36.55%
4.13
Net Other Financing Charges
-34.92
-67.71%
-20.82
-47.67%
-14.10
+29.52%
-20.01
Changes In Cash
-3.61
-111.07%
32.62
+5.69%
30.86
+129.86%
-103.36
Beginning Cash Position
109.75
+42.28%
77.13
+66.69%
46.27
-69.08%
149.63
End Cash Position
106.14
-3.29%
109.75
+42.28%
77.13
+66.69%
46.27
Free Cash Flow
219.38
-6.96%
235.78
+64.65%
143.20
+915.69%
-17.56
Interest Paid Supplemental Data
101.24
-17.06%
122.07
-3.29%
126.23
+15.93%
108.89
Income Tax Paid Supplemental Data
24.28
+71.74%
14.14
-4.18%
14.76
-1.29%
14.95
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Sale Of Business
120.42
0.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category